Bill tracker, H.R. 10628, Health

Biosimilars Access and Affordability Act

  1. Introduced
  2. In committee
  3. Reported
  4. Passed the House
  5. Passed the Senate
  6. To the President
  7. Became law

Introduced Sep 28, 2026 with 11 cosponsors. Latest action Sep 28, 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsor

Committees

Timeline

CommitteeHouseSenatePresidentOctSep 28, 2026: Introduced in HouseSep 28, 2026: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
PassedFailed, tabled or vetoedBecame lawOther steps

Related bills

Full history

    • ReferredHouse. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    • IntroducedIntroduced in House

Read the bill on Congress.gov